These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36535598)

  • 21. A Bacterial Nanomedicine Combines Photodynamic-Immunotherapy and Chemotherapy for Enhanced Treatment of Oral Squamous Cell Carcinoma.
    Shi E; Shan T; Wang H; Mao L; Liang Y; Cao M; Wu Q; Li C; Wang Y; Wang Y
    Small; 2023 Dec; 19(52):e2304014. PubMed ID: 37653616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.
    Chu PL; Shihabuddeen WA; Low KP; Poon DJJ; Ramaswamy B; Liang ZG; Nei WL; Chua KLM; Thong PSP; Soo KC; Yeo ELL; Chua MLK
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():367-374. PubMed ID: 31299389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advantages of salvage photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.
    Minamide T; Yoda Y; Hori K; Shinmura K; Oono Y; Ikematsu H; Yano T
    Surg Endosc; 2020 Feb; 34(2):899-906. PubMed ID: 31139985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.
    Bhuvaneswari R; Ng QF; Thong PS; Soo KC
    Oncotarget; 2015 May; 6(15):13487-505. PubMed ID: 25918252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
    Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy and the treatment of head and neck neoplasia.
    Biel MA
    Laryngoscope; 1998 Sep; 108(9):1259-68. PubMed ID: 9738739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases.
    Dilkes MG; Benjamin E; Ovaisi S; Banerjee AS
    J Laryngol Otol; 2003 Sep; 117(9):713-7. PubMed ID: 14561360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Alexander Mosse C; Morcos M; Hopper C
    Lasers Surg Med; 2011 Aug; 43(6):463-9. PubMed ID: 21761416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas.
    Wang X; Li S; Liu H
    Photodiagnosis Photodyn Ther; 2021 Jun; 34():102218. PubMed ID: 33592329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
    Kübler AC; de Carpentier J; Hopper C; Leonard AG; Putnam G
    Int J Oral Maxillofac Surg; 2001 Dec; 30(6):504-9. PubMed ID: 11829232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.
    Yano T; Kasai H; Horimatsu T; Yoshimura K; Teramukai S; Morita S; Tada H; Yamamoto Y; Kataoka H; Kakushima N; Ishihara R; Isomoto H; Muto M
    Oncotarget; 2017 Mar; 8(13):22135-22144. PubMed ID: 28212527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of photodynamic therapy on treatment response and survival in patients with recurrent oral squamous cell carcinoma: A systematic review.
    Cardoso M; Marto CM; Paula A; Coelho AS; Amaro I; Pineiro M; Pinho E Melo TMVD; Marques Ferreira M; Botelho MF; Carrilho E; Laranjo M
    Photodiagnosis Photodyn Ther; 2024 Aug; 48():104242. PubMed ID: 38857775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbon dots with intrinsic theranostic properties for photodynamic therapy of oral squamous cell carcinoma.
    Kong T; Liu T; Zhang Y; Wang M
    J Biomater Appl; 2022 Nov; 37(5):850-858. PubMed ID: 35856880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer.
    Karakullukcu B; Stoker SD; Wildeman AP; Copper MP; Wildeman MA; Tan IB
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):1093-7. PubMed ID: 22773192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models.
    Sahovaler A; Valic MS; Townson JL; Chan HHL; Zheng M; Tzelnick S; Mondello T; Pener-Tessler A; Eu D; El-Sayes A; Ding L; Chen J; Douglas CM; Weersink R; Muhanna N; Zheng G; Irish JC
    Cancer Res Commun; 2024 Mar; 4(3):796-810. PubMed ID: 38421899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients.
    Karakullukcu B; van Oudenaarde K; Copper MP; Klop WM; van Veen R; Wildeman M; Bing Tan I
    Eur Arch Otorhinolaryngol; 2011 Feb; 268(2):281-8. PubMed ID: 20706842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis.
    Cerrati EW; Nguyen SA; Farrar JD; Lentsch EJ
    Ear Nose Throat J; 2015 Feb; 94(2):72-9. PubMed ID: 25651350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
    de Visscher SA; Dijkstra PU; Tan IB; Roodenburg JL; Witjes MJ
    Oral Oncol; 2013 Mar; 49(3):192-210. PubMed ID: 23068024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nimotuzumab shows an additive effect to inhibit cell growth of ALA-PDT treated oral cancer cells.
    He X; Hu N; Yang S; Yang Z; Hu L; Wang X; Wen N
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102817. PubMed ID: 35331955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined concurrent photodynamic and gold nanoshell loaded macrophage-mediated photothermal therapies: an in vitro study on squamous cell head and neck carcinoma.
    Trinidad AJ; Hong SJ; Peng Q; Madsen SJ; Hirschberg H
    Lasers Surg Med; 2014 Apr; 46(4):310-8. PubMed ID: 24648368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.